SCHEMBL3483934

SCHEMBL3483934

Cc1ccc(Oc2cccc(OC(C)(C)C(=O)OC(C)(C)C)c2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.43
TDP1 Q9NUW8 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
PPARA Q07869 2/20 0.41
PPARD Q03181 1/20 0.41
PPARG P37231 3/20 0.41
FFAR4 Q5NUL3 1/20 0.41
FFAR1 O14842 1/20 0.40
HSD17B1 P14061 2/20 0.39
HSD17B2 P37059 2/20 0.39
MTNR1A P48039 1/20 0.39
MTNR1B P49286 1/20 0.39
ALDH1A1 P00352 2/20 0.39
GCK P35557 1/20 0.39
FBP1 P09467 1/20 0.39
POLB P06746 2/20 0.39
NPC1 O15118 1/20 0.39
CYP2C9 P11712 1/20 0.39
RAB9A P51151 1/20 0.39
MMP13 P45452 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3484168 0.88 PPARA (0.46) HTTTDP1PPARAPPARDPPARG
SCHEMBL3484402 0.84 PPARG (0.44) PPARAPPARDPPARGMTNR1AMTNR1B
SCHEMBL4040746 0.84 PPARG (0.55) HTTTDP1L3MBTL1PPARAPPARD
SCHEMBL3484948 0.83 CYP1A2 (0.46) PPARAPPARGFFAR4FFAR1FBP1
SCHEMBL3484278 0.80 PPARG (0.39) PPARAPPARGMTNR1AMTNR1BFBP1
SCHEMBL3484397 0.77 FFAR4 (0.41) HTTTDP1L3MBTL1PPARGFFAR4
SCHEMBL4576129 0.77 CYP1A2 (0.41) PPARAPPARGALDH1A1FBP1CYP2C9
SCHEMBL14943944 0.77 CYP3A4 (0.44) PPARAPPARGALDH1A1FBP1POLB
SCHEMBL30609812 0.77 CYP1A2 (0.41) PPARAPPARGALDH1A1FBP1CYP2C9
SCHEMBL2436622 0.75 AKR1C3 (0.50) PPARAPPARGPOLBNPC1CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100004159-A1 SUBSTITUTED IMIDAZOLONE DERIVATIVES, PREPARATIONS AND USES GENFIT (FR) 2010-01-07 US disclosed
US-20100004159-A1 SUBSTITUTED IMIDAZOLONE DERIVATIVES, PREPARATIONS AND USES GENFIT (FR) 2010-01-07 US disclosed
US-20100004159-A1 SUBSTITUTED IMIDAZOLONE DERIVATIVES, PREPARATIONS AND USES GENFIT (FR) 2010-01-07 US disclosed
WO-2008012470-A2 SUBSTITUTED IMIDAZOLONE DERIVATIVES, PREPARATION AND USES GENFIT (FR) 2008-01-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100004159-A1 SUBSTITUTED IMIDAZOLONE DERIVATIVES, PREPARATIONS AND USES IPO5, PPIP5K2, IPO4 HTT 321/4885TDP1 2237/4885L3MBTL1 4843/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.